Welcome!

News Feed Item

CCRM Introduces New Leadership to Drive Company Creation Strategy

TORONTO, ONTARIO -- (Marketwired) -- 01/31/14 -- The Centre for Commercialization of Regenerative Medicine (CCRM) is focusing on company creation to bridge the commercialization gap and accelerate the therapeutic potential of regenerative medicine technologies and stem cell therapies. To guide and support this strategy, CCRM welcomes Gail Naughton, CEO of Histogen, Inc. and Susan Solomon, CEO of the New York Stem Cell Foundation to CCRM's Board of Directors. David Smith, who runs the global Therapeutic Cell Solutions unit for Lonza and joined the Board in 2013, has been re-elected for a second term. Also joining CCRM are James Parsons in the role of Chief Financial Officer and Michael Israels as Chief Operating Officer.

"CCRM has emerged as an international leader in regenerative medicine commercialization, with advice and support from the strong, knowledgeable, experienced leaders on the Board," explains Greg Bonfiglio, CCRM Board Chair and Managing Partner of Proteus Venture Partners. "We greatly appreciate David's ongoing contributions, and we look forward to Gail's and Susan's invaluable counsel and expertise as CCRM sharpens its focus on company creation."

Dr. Naughton joins CCRM's Board of Directors with more than 25 years of experience researching the tissue engineering process. She holds over 95 U.S. and foreign patents, and was a previous recipient of the annual National Inventor of the Year Award by the Intellectual Property Owners. Dr. Naughton is Founder, CEO and Chair of Histogen Inc., a regenerative medicine company developing treatments for conditions including hair loss and cancer. She was also a founder of Advanced Tissue Sciences, a leading tissue engineering company.

Ms. Solomon is Co-Founder and CEO of The New York Stem Cell Foundation, which shares CCRM's mandate to accelerate cures through stem cell research. A longtime health-care advocate with a professional background in finance, media and technology, she has made the Foundation an international leader in developing new stem cell technologies and in using human cells for drug development and disease modeling. In 2008, she received the New York State Women of Excellence Award from the Governor of New York and the Triumph Award from the Brooke Ellison Foundation. In 2012, Ms. Solomon received the Stem Cell Action Leadership Award from the Genetics Policy Institute.

After a long and successful career at The Upjohn Company, Mr. Smith was Business Unit Director for Invitrogen and then Vice President, Corporate Development at Claragen Inc. He then moved to Cambrex Bioproducts, in the cell therapy business, and remained in a leadership position when the company was acquired by Lonza in 2007. Today, he is Head, Lonza, Cell Therapy Manufacturing.

"CCRM has grown very quickly since its launch," says Michael May, CEO of the Centre for Commercialization of Regenerative Medicine. "James and Michael are valuable additions to our executive leadership team who are guiding the organization and putting essential processes into place to execute on projects and spin-off new companies."

In addition to his appointment at CCRM, Mr. Parsons is also the CFO at Stem Cell Therapeutics Corp. His extensive experience includes roles at Amorfix Life Sciences Ltd., DiaMedica Inc., Rimon Therapeutics Ltd., Trillium Therapeutics and YM BioSciences Inc.

Mr. Israels has assumed the position of COO at CCRM. Prior to joining CCRM, Mr. Israels was a Management Consultant at Ernst & Young LLP, President of BEST Funds, a venture capital company, and CEO of Convexus Managed Services Inc., a start-up fund administration company.

The new board members fill vacancies left by the departures of Dr. Ruth McKernan, SVP of Pfizer Inc. and CSO of Neusentis Inc., Dr. Melissa Carpenter, Principal at Carpenter Group Consulting and Ms. Lita Nelsen, Director of the Technology Licensing Office at the Massachusetts Institute of Technology, whose terms have ended. On behalf of CCRM and the Board, Mr. Bonfiglio thanks Drs. McKernan and Carpenter, and Ms. Nelsen for their significant contributions as founding members of the Board of Directors.

About the Centre for Commercialization of Regenerative Medicine

CCRM, a Canadian not-for-profit organization funded by the Government of Canada's Networks of Centres of Excellence program and six academic partners, supports the development of technologies that accelerate the commercialization of stem cell- and biomaterials-based technologies and therapies. A network of academics, industry and entrepreneurs, CCRM aims to translate scientific discoveries into marketable products for patients. CCRM launched in Toronto's Discovery District on June 14, 2011. CCRM is hosted by the University of Toronto.

Contacts:
CCRM
Stacey Johnson
Director of Communications
647-309-1830
[email protected]
www.ccrm.ca

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
To Really Work for Enterprises, MultiCloud Adoption Requires Far Better and Inclusive Cloud Monitoring and Cost Management … But How? Overwhelmingly, even as enterprises have adopted cloud computing and are expanding to multi-cloud computing, IT leaders remain concerned about how to monitor, manage and control costs across hybrid and multi-cloud deployments. It’s clear that traditional IT monitoring and management approaches, designed after all for on-premises data centers, are falling short in ...
Without lifecycle traceability and visibility across the tool chain, stakeholders from Planning-to-Ops have limited insight and answers to who, what, when, why and how across the DevOps lifecycle. This impacts the ability to deliver high quality software at the needed velocity to drive positive business outcomes. In his general session at @DevOpsSummit at 19th Cloud Expo, Eric Robertson, General Manager at CollabNet, will discuss how customers are able to achieve a level of transparency that e...
It is ironic, but perhaps not unexpected, that many organizations who want the benefits of using an Agile approach to deliver software use a waterfall approach to adopting Agile practices: they form plans, they set milestones, and they measure progress by how many teams they have engaged. Old habits die hard, but like most waterfall software projects, most waterfall-style Agile adoption efforts fail to produce the results desired. The problem is that to get the results they want, they have to ch...
Organizations planning enterprise data center consolidation and modernization projects are faced with a challenging, costly reality. Requirements to deploy modern, cloud-native applications simultaneously with traditional client/server applications are almost impossible to achieve with hardware-centric enterprise infrastructure. Compute and network infrastructure are fast moving down a software-defined path, but storage has been a laggard. Until now.
"Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
"We're focused on how to get some of the attributes that you would expect from an Amazon, Azure, Google, and doing that on-prem. We believe today that you can actually get those types of things done with certain architectures available in the market today," explained Steve Conner, VP of Sales at Cloudistics, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
For far too long technology teams have lived in siloes. Not only physical siloes, but cultural siloes pushed by competing objectives. This includes informational siloes where business users require one set of data and tech teams require different data. DevOps intends to bridge these gaps to make tech driven operations more aligned and efficient.
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service.
DXWorldEXPO LLC announced today that the upcoming DXWorldEXPO | CloudEXPO New York event will feature 10 companies from Poland to participate at the "Poland Digital Transformation Pavilion" on November 12-13, 2018.
Digital Transformation is much more than a buzzword. The radical shift to digital mechanisms for almost every process is evident across all industries and verticals. This is often especially true in financial services, where the legacy environment is many times unable to keep up with the rapidly shifting demands of the consumer. The constant pressure to provide complete, omnichannel delivery of customer-facing solutions to meet both regulatory and customer demands is putting enormous pressure on...
The best way to leverage your CloudEXPO | DXWorldEXPO presence as a sponsor and exhibitor is to plan your news announcements around our events. The press covering CloudEXPO | DXWorldEXPO will have access to these releases and will amplify your news announcements. More than two dozen Cloud companies either set deals at our shows or have announced their mergers and acquisitions at CloudEXPO. Product announcements during our show provide your company with the most reach through our targeted audienc...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors!
In an era of historic innovation fueled by unprecedented access to data and technology, the low cost and risk of entering new markets has leveled the playing field for business. Today, any ambitious innovator can easily introduce a new application or product that can reinvent business models and transform the client experience. In their Day 2 Keynote at 19th Cloud Expo, Mercer Rowe, IBM Vice President of Strategic Alliances, and Raejeanne Skillern, Intel Vice President of Data Center Group and ...
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smart...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...